To screen or not to screen for pre-type 1 diabetes?

Hormone Research

Volumn 57, Issue SUPPL. 1, 2002, Pages 12-17

  Schatz, Desmond ^a,d   Krischer, Jeffrey ^c   She, Jin Xiong ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Diabetes prevention; Diabetes screening; Immunopathogenesis; Prediabetic period; Type 1 diabetes

Indexed keywords

C PEPTIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; INSULIN; NICOTINAMIDE; PANCREAS ISLET CELL ANTIBODY;

ANTIBODY TITER; CLINICAL TRIAL; CONFERENCE PAPER; EARLY DIAGNOSIS; GENE INTERACTION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOGENETICS; IMMUNOPATHOGENESIS; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCREENING; STRESS;

DIABETES MELLITUS, TYPE 1; HUMANS; MASS SCREENING;

EID: 0036242426     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053306     Document Type: Conference Paper

References (32)

1. Epidemiology of childhood diabetes mellitus in Finland - Background of a nationwide study of Type 1 (insulin-dependent) diabetes mellitus
2. High IDDM incidence over 4 years in Sardinia
3. Diabetes mellitus in the child and adolescent
4. Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications
5. Economic consequences of diabetes mellitus in the U.S. in 1997
6. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
7. Is now the time for an intervention to prevent autoimmune type 1 diabetes
8. The natural history of pre-type 1 diabetes
9. Age-corrected empirical genetic risk estimates for first degree relatives of IDDM patients
10. The significance of the concordance rate for type 1 (insulin dependent) diabetes in identical twins
11. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes
12. Insulin and islet cell autoantibodies as time dependent covariates in the development of insulin dependent diabetes: A prospective study in relatives
13. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
14. Only multiple antibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2 beta predict immune mediated (type 1) diabetes in relatives
15. Type 1 diabetes: Polygenic inheritance, multiple autoantigens and 'dual' parameter prediction
16. Islet cell antibodies predict insulin dependent diabetes in U.S. school age children as powerfully as in unaffected relatives
17. Rubella infection and diabetes mellitus
18. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM
19. The case for elimination of cow's milk in early infancy in the prevention of type 1 diabetes: The Finnish experience
20. Type 1 diabetes
21. DPT-1 Study Group: Undiagnosed hypergly-cemia in relatives of type 1 diabetes patients
22. DPT-1 Study Group: The Diabetes Prevention Trial (DPT-1): Implementation of screening and staging of relatives
23. Intranasal insulin trial in preclinical Type 1 diabetes
24. Direct costs of type 1 diabetes prevention based on nasal insulin: A simulation model for the DIPP project
25. Theory and practice of nicotinamide trials in pre-type 1 diabetes
26. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes
27. Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY)
28. From pathomechanisms to prediction, prevention and improved care of insulin-dependent diabetes mellitus in children
29. Prospective assessment in newborns for diabetes autoimmunity (PANDA): A newborn diabetes screening program in the general population of Florida
30. Early environmental events as a cause of IDDM: Evidence and implications
31. Psychologic impact of islet cell antibody screening for IDDM on children, adults, and their family members
32. Screening programs to identify children at risk for diabetes mellitus: Psychological impact on children and parents